Complex Trauma in Adolescents and Adults: Effects and Treatment

Psychiatric Clinics of North America

Volumn 38, Issue 3, 2015, Pages 515-527

  Briere, John ^a   Scott, Catherine ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Complex PTSD; Complex trauma; PTSD; Trauma; Treatment of complex trauma

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; AFFECT REGULATION TRAINING; BEHAVIOR CHANGE; BIPOLAR DISORDER; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; DISEASE ASSOCIATION; DRUG EFFICACY; HUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHODYNAMIC PSYCHOTHERAPY; PSYCHOTHERAPY; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; TREATMENT RESPONSE; DISSOCIATIVE DISORDERS; LIFE EVENT; STRESS DISORDERS, POST-TRAUMATIC;

DISSOCIATIVE DISORDERS; HUMANS; LIFE CHANGE EVENTS; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; RISK FACTORS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84941171749     PISSN: 0193953X     EISSN: 15583147     Source Type: Journal    
DOI: 10.1016/j.psc.2015.05.004     Document Type: Review

References (93)

1. Briere J., Spinazzola J. Phenomenology and psychological assessment of complex posttraumatic states. J Trauma Stress 2005, 18:401-412.
2. Cook A., Spinazzola J., Ford J., et al. Complex trauma in children and adolescents. Psychiatr Ann 2005, 35:390-398.
3. Briere J., Kaltman S., Green B.L. Accumulated childhood trauma and symptom complexity. J Trauma Stress 2008, 21:223-226.
4. Cloitre M., Stolbach B.C., Herman J.L., et al. A developmental approach to complex PTSD. Childhood and adult cumulative trauma as predictors of symptom complexity. J Trauma Stress 2009, 22:399-408.
5. Hodges M., Godbout N., Briere J., et al. Cumulative trauma and symptom complexity in children: a path analysis. Child Abuse Negl 2013, 37:891-898.
6. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2013, American Psychiatric Publishing, Washington, DC. 5th edition.
7. Breslau N., Chilcoat H.D., Kessler R.C., et al. Previous exposure to trauma and PTSD effects of subsequent trauma: results from the Detroit area survey of trauma. Am J Psychiatry 1999, 156:902-907.
8. Karam E.G., Friedman M.J., Hill E.D., et al. Cumulative traumas and risk thresholds: 12-month PTSD in the World Mental Health (WMH) surveys. Depress Anxiety 2014, 31:130-142.
9. Kilpatrick D.G., Resnick H.S., Milanak M.E., et al. National estimates of exposure to traumatic events and PTSD prevalence using DSM-IV and DSM-5 criteria. J Trauma Stress 2013, 26:537-547.
10. Walsh K., Danielson C.K., McCauley J.L., et al. National prevalence of posttraumatic stress disorder among sexually revictimized adolescent, college, and adult household-residing women. Arch Gen Psychiatry 2012, 69:935-942.
11. Briere J. Psychological assessment of adult posttraumatic states: phenomenology, diagnosis, and measurement 2004, American Psychological Association, Washington, DC. 2nd edition.
12. Classen C.C., Palesh O.G., Aggarwal R. Sexual revictimization: a review of the empirical literature. Trauma Violence Abuse 2005, 6:103-129.
13. Ford J.D. Treatment implications of altered affect regulation and information processing following child maltreatment. Psychiatr Ann 2005, 35:410-419.
14. Breslau N., Davis G.C., Andreski P., et al. Traumatic events and posttraumatic stress disorder in an urban population of young adults. Arch Gen Psychiatry 1991, 48:216-222.
15. Nickerson A., Aderka I.M., Bryant R.A., et al. The relationship between childhood exposure to trauma and intermittent explosive disorder. Psychiatry Res 2012, 197:128-134.
16. Briere J., Hodges M., Godbout N. Traumatic stress, affect dysregulation, and dysfunctional avoidance: a structural equation model. J Trauma Stress 2010, 23:767-774.
17. Ouimette P., Brown P.J. Trauma and substance abuse: causes, consequences, and treatment of comorbid disorders 2003, American Psychological Association, Washington, DC.
18. Briere J., Godbout N., Dias C. Trauma, hyperarousal, and suicidality: a path analysis. J Trauma Dissociation 2015, 16(2):153-169.
19. Briere J., Scott C., Weathers F.W. Peritraumatic and persistent dissociation in the presumed etiology of PTSD. Am J Psychiatry 2005, 162:2295-2301.
20. Complex Trauma Taskforce. The ISTSS Expert Consensus treatment guidelines for complex PTSD in adults. 2012. Available at: . Accessed June 11, 2015. http://www.istss.org/ISTSS_Main/media/Documents/ISTSS-Expert-Concesnsus-Guidelines-for-Complex-PTSD-Updated-060315.pdf.
21. Follette V.M., Polusny M.A., Bechtle A.E., et al. Cumulative trauma: the impact of child sexual abuse, adult sexual assault, and spouse abuse. J Trauma Stress 1996, 9:25-35.
22. Herman J.L. Complex PTSD: a syndrome in survivors of prolonged and repeated trauma. J Trauma Stress 1992, 5:377-392.
23. van der Kolk B.A., Roth S., Pelcovitz D., et al. Disorders of extreme stress: the empirical foundation of a complex adaptation to trauma. J Trauma Stress 2005, 18:389-399.
24. Gunderson J. Borderline personality disorder. N Engl J Med 2011, 364:2037-2042.
25. van der Kolk B.A. Developmental trauma disorder: towards a rational diagnosis for chronically traumatized children. Psychiatr Ann 2005, 35:401-408.
26. World Health Organization International statistical classification of diseases and related health problems (10th revision) 1992, World Health Organization, Geneva (Switzerland).
27. Foa E.B., Hembree E.A., Rothbaum B.O. Prolonged exposure therapy for PTSD: emotional processing of traumatic experiences: therapist guide 2007, Oxford University Press, New York.
28. Friedman M.J., Davidson J.R., Stein D.J. Psychopharmacotherapy for adults. Effective treatments for PTSD: practice guidelines from the International Society for Traumatic Stress Studies 2009, 245-268. Guilford, New York. E.B. Foa, T.M. Keane, M.J. Friedman (Eds.).
29. Effective treatments for PTSD: practice guidelines from the International Society for Traumatic Stress Studies 2008, The Guilford Press, New York. 2nd edition. E.B. Foa, T.M. Keane, M.J. Friedman (Eds.).
30. Roberts N.P., Kitchiner N.J., Kenardy J., et al. Early psychological interventions to treat acute traumatic stress symptoms. Cochrane Database Syst Rev 2010, (3). CD007944.
31. Resick P.A., Schnicke M.K. Cognitive processing therapy for rape victims: a treatment manual 1993, Sage, Newbury Park (CA).
32. Shapiro F. Eye movement desensitization and reprocessing: basic principles, protocols, and procedures 1995, Guilford, New York.
33. Briere J., Scott C. Principles of trauma therapy: a guide to symptoms, evaluation, and treatment 2014, DSM-5 update, Sage, Thousand Oaks (CA). 2nd edition.
34. Blaustein M.E., Kinniburgh K.M. Treating traumatic stress in children and adolescents: how to foster resilience through attachment, self-regulation, and competency 2010, Guilford Publications, New York.
35. Briere J., Lanktree C.B. Treating complex trauma in adolescents and young adults 2011, Sage, Thousand Oaks (CA).
36. Cloitre M., Stovall-McClough K.C., Nooner K., et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry 2010, 167:915-924.
37. Ford J.D., Russo E. A trauma-focused, present-centered, emotion self-regulation approach to integrated treatment for PTSD and addiction. Am J Psychother 2006, 60:335-355.
38. Linehan M.M. Cognitive-behavioral treatment of borderline personality disorder 1993, Guilford, New York.
39. Lampe A., Mitmansgruber H., Gast U., et al. [Treatment outcome of psychodynamic trauma therapy in an inpatient setting]. Neuropsychiatr 2008, 22:189-197. [in German].
40. Schottenbauer M.A., Glass C.R., Arnkoff D.B., et al. Contributions of psychodynamic approaches to treatment of PTSD and trauma: a review of the empirical treatment and psychopathology literature. Psychiatry 2008, 71:13-34.
41. Lambert M.J., Barley D.E. Research summary on the therapeutic relationship and psychotherapy outcome. Psychother Theor Res Pract Train 2001, 38:357-361.
42. Habib M., Labruna V., Newman J. Complex histories and complex presentations: implementation of a manually-guided group treatment for traumatized adolescents. J Fam Violence 2013, 28:717-728.
43. Linehan M.M., Comtois K.A., Murray A.M. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry 2006, 63:757-766.
44. Spinazzola J., Blaustein M., van der Kolk B.A. Posttraumatic stress disorder treatment outcome research: the study of unrepresentative samples?. J Trauma Stress 2005, 18(5):425-436.
45. Cahill S.P., Rothbaum B.O., Resick P.A., et al. Cognitive behavioral therapy for adults. Effective treatments for PTSD: practice guidelines from the International Society for Traumatic Stress Studies 2009, 139-222. Guilford, New York. E.B. Foa, T.M. Keane, M.J. Friedman (Eds.).
46. Cukor J., Difede J. Review: psychotherapy, somatic therapy and pharmacotherapy are all more effective than control for the treatment of PTSD. Evid Based Ment Health 2014, 17(1):7. Accessed January 21, 2015.
47. Davidson J.R.T., Rothbaum B.O., van der Kolk B.A., et al. Multi-center, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry 2001, 58:485-492.
48. Stein D.J., Davidson J., Seedat S., et al. Paroxetine in the treatment of post-traumatic stress disorder: pooled analysis of placebo-controlled studies. Expert Opin Pharmacother 2003, 4:1829-1838.
49. Martenyi F., Soldatenkova V. Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: analysis of the veteran group of a placebo-controlled, randomized clinical trial. Eur Neuropsychopharmacol 2006, 16:340-349.
50. Pae C.U., Lim H.K., Ajwani N., et al. Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder. Expert Rev Neurother 2007, 7(6):603-615.
51. Davidson J.R.T., Weisler R.H., Butterfield M.I., et al. Mirtazapine vs placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry 2003, 53:188-191.
52. Becker M.E., Hertzberg M.A., Moore S.D., et al. A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. J Clin Psychopharmacol 2007, 27:193-197.
53. Frank J.B., Kosten T.R., Giller E.L., et al. A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. Am J Psychiatry 1988, 145:1289-2291.
54. Reist C., Kauffmann C.D., Haier R.J., et al. A controlled trial of desipramine in 18 men with posttraumatic stress disorder. Am J Psychiatry 1989, 146:513-516.
55. American Psychiatric Association (APA). Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Psychiatry Online. 2004. Available at: . Accessed June 11, 2015. http://psychiatryonline.org/pb/assets/raw/sitewide/practice:guidelines/guidelines/acutestressdisorderptsd.pdf.
56. Braun P., Greenberg D., Dasberg H., et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J Clin Psychiatry 1990, 51:236-238.
57. Gelpin E., Bonne O., Peri T., et al. Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry 1996, 57:390-394.
58. Girard T.D., Shintani A.K., Jackson J.C., et al. Risk factors for post-traumatic stress disorder symptoms following critical illness requiring mechanical ventilation: a prospective cohort study. Crit Care 2007, 11:28.
59. Hertzberg M.A., Butterfield M.I., Feldman M.E., et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry 1999, 45:1226-1229.
60. Hamner M.B., Faldowski R.A., Robert S., et al. A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry 2009, 21:89-94.
61. Keck P., McElroy S., Friedman L. Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. J Clin Psychopharmacol 1992, 12:368-418.
62. Connor K.M., Davidson J.R., Weisler R.H., et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl) 2006, 184:21-25.
63. Jiménez J.P., Romero C.C., Diéguez N.G., et al. Pharmacological treatment of acute stress disorder with propranolol and hypnotics. Actas Esp Psyquiatr 2007, 35(6):351-358.
64. Vaiva G., Ducrocq F., Jezequel K., et al. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol Psychiatry 2003, 52:947-949.
65. Pitman R.K., Sanders K.M., Zusman R.M. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry 2002, 51:189-192.
66. Stein M.B., Kerridge C., Dimsdale J.E., et al. Pharmacotherapy to prevent PTSD: results from a randomized controlled proof-of-concept trial in physically injured patients. J Trauma Stress 2007, 20(6):923-932.
67. Kolb L.C., Burris B.C., Griffiths S. Propranolol and clonidine in the treatment of the chronic post-traumatic stress disorders of war. Posttraumatic stress disorder: psychological and biological sequelae 1984, 98-108. American Psychiatric Press, Washington, DC. B.A. van der Kolk (Ed.).
68. Kinzie J.D., Leung P. Clonidine in Cambodian patients with posttraumatic stress disorder. J Nerv Ment Dis 1989, 177:546-550.
69. Taylor F.B., Martin P., Thompson C., et al. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry 2008, 63:629-632.
70. Raskind M.A., Peskind E.R., Kanter E.D., et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry 2003, 160:371-373.
71. Monnelly E.P., Ciraulo D.A. Risperidone effects on irritable aggression in posttraumatic stress disorder. J Clin Psychopharmacol 1999, 19:377-378.
72. Rothbaum B.O., Killeen T.K., Davidson J.R., et al. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J Clin Psychiatry 2008, 69:520-525.
73. Krystal J.H., Rosenheck R.A., Cramer J.A. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA 2011, 306:493-502.
74. Stein M.B., Kline N.A., Matloff J.L. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry 2002, 159:1777-1779.
75. Butterfield M.I., Becker M.E., Connor K.M., et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol 2001, 16:197-203.
76. Carey P., Suliman S., Ganesan K., et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol 2012, 27(4):386-391.
77. Wang H.R., Woo Y.S., Bahk W.M. Atypical antipsychotics in the treatment of posttraumatic stress disorder. Clin Neuropharmacol 2013, 36(6):216-222.
78. Bohus M.J., Landwehrmeyer G.B., Stiglmayr C.E., et al. Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial. J Clin Psychiatry 1999, 60:598-603.
79. Schmahl C., Kleindienst N., Limberger M., et al. Evaluation of naltrexone for dissociative symptoms in borderline personality disorder. Int Clin Psychopharmacol 2012, 27(1):61-68.
80. Simeon D., Knutelska M. An open trial of naltrexone in the treatment of depersonalization disorder. J Clin Psychopharmacol 2005, 25(3):267-270.
81. Preve M., Mula M., Cassano G., et al. Venlafaxine in somatopsychic and autopsychic depersonalization. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35(8):1808-1809.
82. Simeon D., Guralnik O., Schmeidler J., et al. Fluoxetine therapy in depersonalisation disorder: randomised controlled trial. Br J Psychiatry 2004, 185:31-36.
83. Sierra M., Phillips M.L., Lambert M.V., et al. Lamotrigine in the treatment of depersonalization disorder. J Clin Psychiatry 2001, 62(10):826-827.
84. Sierra M., Phillips M.L., Ivin G., et al. A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder. J Psychopharmacol 2003, 17(1):103-105.
85. Uguz F., Sahingoz M. Aripiprazole in depersonalization disorder comorbid with major depression and obsessive-compulsive disorder: 3 cases. Clin Neuropharmacol 2014, 37(4):125-127.
86. American Psychiatric Association Practice guideline for the treatment of patients with borderline personality disorder 2001, Author, Washington, DC.
87. National Institute for Clinical Excellence (NICE). Borderline personality disorder: treatment and management. 2009. Available at: . Accessed January 21, 2015. https://www.nice.org.uk/guidance/cg78/resources/guidance-borderline-personality-disorder-pdf.
88. Lieb K., Völlm B., Rücker G., et al. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry 2010, 196(1):4-12.
89. Bellino S., Rinaldi C., Bozzatello P., et al. Pharmacotherapy of borderline personality disorder: a systematic review for publication purpose. Curr Med Chem 2011, 18(22):3322-3329.
90. Hollander E., Allen A., Lopez R.P., et al. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. J Clin Psychiatry 2001, 62(3):199-203.
91. Frankenburg F.R., Zanarini M.C. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study. J Clin Psychiatry 2002, 63(5):442-446.
92. Loew T.H., Nickel M.K., Muehlbacher M., et al. Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study. J Clin Psychopharmacol 2006, 26(1):61-66.
93. Zanarini M.C., Frankenberg F.R. Olanzapine treatment of female borderline personality disorder patients: a double blind, placebo-controlled pilot study. J Clin Psychiatry 2001, 62(11):849-854.